Alterola Biotech Valuation
| ABTI Stock | USD 0.0002 0.00 0.00% |
Alterola Biotech seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Alterola Biotech from analyzing the firm fundamentals such as Current Valuation of 68.08 M, price to book of 6.29 X, and Return On Equity of -1.27 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Alterola Biotech's price fluctuation is out of control at this time. Calculation of the real value of Alterola Biotech is based on 3 months time horizon. Increasing Alterola Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Alterola Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alterola Pink Sheet. However, Alterola Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.0E-4 | Real 1.92E-4 | Hype 1.23E-4 | Naive 1.23E-4 |
The intrinsic value of Alterola Biotech's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Alterola Biotech's stock price.
Estimating the potential upside or downside of Alterola Biotech helps investors to forecast how Alterola pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alterola Biotech more accurately as focusing exclusively on Alterola Biotech's fundamentals will not take into account other important factors: Alterola Biotech Total Value Analysis
Alterola Biotech is presently anticipated to have valuation of 68.08 M with market capitalization of 39.55 M, debt of 251.18 K, and cash on hands of 61.54 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Alterola Biotech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
68.08 M | 39.55 M | 251.18 K | 61.54 K |
Alterola Biotech Asset Utilization
One of the ways to look at asset utilization of Alterola is to check how much profit was generated for every dollar of assets it reports. Alterola Biotech shows a negative utilization of assets of -0.67 percent, losing $0.006669 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Alterola Biotech shows how discouraging it operates for each dollar spent on its assets.Alterola Biotech Profitability Analysis
Net Loss for the year was (6.47 M) with profit before overhead, payroll, taxes, and interest of 0.About Alterola Biotech Valuation
An absolute valuation paradigm, as applied to Alterola Pink Sheet, attempts to find the value of Alterola Biotech based on its fundamental and basic technical indicators. By analyzing Alterola Biotech's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Alterola Biotech's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alterola Biotech. We calculate exposure to Alterola Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Alterola Biotech's related companies.Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products production of active pharmaceutical ingredients and food-grade ingredients and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech is traded on OTC Exchange in the United States.
8 Steps to conduct Alterola Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Alterola Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Alterola Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Alterola Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Alterola Biotech's revenue streams: Identify Alterola Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Alterola Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Alterola Biotech's growth potential: Evaluate Alterola Biotech's management, business model, and growth potential.
- Determine Alterola Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Alterola Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Alterola Biotech Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 770 M | |
| Retained Earnings | -7970.51 | |
| Shares Float | 163.6 M |
Complementary Tools for Alterola Pink Sheet analysis
When running Alterola Biotech's price analysis, check to measure Alterola Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterola Biotech is operating at the current time. Most of Alterola Biotech's value examination focuses on studying past and present price action to predict the probability of Alterola Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterola Biotech's price. Additionally, you may evaluate how the addition of Alterola Biotech to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |